> Ozempic / Wegovy… seemingly started as a “designer” drug for celebrities and rich folks to lose weight
The term “designer drug” means something else. Ozempic has been in use in humans for over 15 years as a treatment for diabetes.
> Nearly 2/3rds of patients who stopped taking Wegovy gained back the weight they had previously lost, less than 1 year after stopping the usage of the drug. <source>. What does this sound like? Dependence.
No, this is not what is meant by a drug dependence.
> I’m not here to claim to be an expert on any of this — because I certainly am not. In fact, I am probably the exact opposite of that in this space… I am not a medical professional...
Oh, got it.
One could write an interesting article about adoption curves (people have for phone vs VCR vs TV…) but this isn’t it. It’s just wild speculation.
I am not a “medical professional” but I am a former pharmaceutical designer and founded and ran a pharmaceutical startup.
Sorry to be so harsh; we should be encouraging more blogging. But this post is terrible.
Fair feedback on the designer drug point and drug dependence. What do you suggest as better terms here?
I say many times throughout that I'm not trying to act as a medical professional -- but I am drawing comparisons between the macro trends, which are definitely there.
2 comments
[ 4.7 ms ] story [ 20.7 ms ] threadThe term “designer drug” means something else. Ozempic has been in use in humans for over 15 years as a treatment for diabetes.
> Nearly 2/3rds of patients who stopped taking Wegovy gained back the weight they had previously lost, less than 1 year after stopping the usage of the drug. <source>. What does this sound like? Dependence.
No, this is not what is meant by a drug dependence.
> I’m not here to claim to be an expert on any of this — because I certainly am not. In fact, I am probably the exact opposite of that in this space… I am not a medical professional...
Oh, got it.
One could write an interesting article about adoption curves (people have for phone vs VCR vs TV…) but this isn’t it. It’s just wild speculation.
I am not a “medical professional” but I am a former pharmaceutical designer and founded and ran a pharmaceutical startup.
Sorry to be so harsh; we should be encouraging more blogging. But this post is terrible.
I say many times throughout that I'm not trying to act as a medical professional -- but I am drawing comparisons between the macro trends, which are definitely there.